Prostate cancer: Diagnostic performance of the PCA3 urine test

Nature Reviews Urology

Volumn 8, Issue 3, 2011, Pages 123-124

  Lee, George Leighton ^a   Dobi, Albert ^b   Srivastava, Shiv ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE CANCER ANTIGEN 3; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; DIGITAL RECTAL EXAMINATION; GENE MUTATION; HUMAN; PERFORMANCE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SHORT SURVEY; URINALYSIS;

ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; HUMANS; MALE; MULTICENTER STUDIES AS TOPIC; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 79952635167     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2011.10     Document Type: Short Survey

References (9)

1. Ploussard, G. & de la Taille, A. Urine biomarkers in prostate cancer. Nat. Rev. Urol. 7, 101-109 (2010).
2. Bussemakers, M. J. et al. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res. 59, 5975-5979 (1999).
3. Hessels, D. et al. DD3 (PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur. Urol. 44, 8-15 (2003).
4. Day, J. R., Jost, M., Reynolds, M. A., Groskopf, J. & Rittenhouse, H. PCA3: from basic molecular science to the clinical lab. Cancer Lett. 301, 1-6 (2011).
5. Ploussard, G. et al. The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies? BJU Int. 106, 1143-1147 (2010).
6. Auprich, M. et al. External validation of urinary PCA3-based nomograms to individually predict prostate biopsy outcome. Eur. Urol. 58, 727-732 (2010).
7. Roobol, M. J. et al. Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: exploring the value of PCA3 for a first-line diagnostic test. Eur. Urol. 58, 475-481 (2010).
8. Haese, A. et al. Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy. Eur. Urol. 54, 1081-1088 (2008).
9. Marks, L. S. et al. PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy. Urology 69, 532-535 (2007).